Clinical trial
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural…
NCT00002872 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002872 |
|---|---|
| Title | Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions |
| Official title | A PROSPECTIVE RANDOMIZED TRIAL OF BLEOMYCIN VS. DOXYCYCLINE VS. TALC FOR THE INTRAPLEURAL TREATMENT OF MALIGNANT PLEURAL EFFUSIONS |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Cancer |
| Intervention type | Biological, Drug, Other |
| Interventions | bleomycin sulfate, doxycycline, talc |
| Enrollment | 480 |
| Start date | Jan 10, 1997 |
| Primary completion | Feb 1, 2003 |
| First posted | Sep 2, 2004 |
| Last update posted | Jun 22, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: